A novel mikanolide derivative has been found to exhibit potent antileukemic activity by inhibiting CDC25C phosphorylation, triggering apoptosis, and promoting DNA damage in leukemia cells (Rao et al., 2022). The gene discussed is CDC25C; the disease is leukemia.